Pomerantz investigates HCA Healthcare claims: HCA Healthcare stock pre-market at EUR 411.50
Published on 10/14/2026 at 08:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestigation and trading details
- Pomerantz LLP announced an investigation involving HCA Healthcare on October 13, 2026.
- HCA Healthcare stock trades pre-market at EUR 411.50 at 8:24 a.m. CEST at Lang & Schwarz on October 14, 2026.
- The Lang & Schwarz bid was EUR 409.50 and the ask was EUR 413.50 on October 14, 2026.
Pomerantz LLP said in a GlobeNewswire release dated October 13, 2026, that it was investigating claims on behalf of investors in HCA Healthcare, Inc. The law firm said the investigation concerns whether HCA Healthcare and certain officers or directors engaged in securities fraud or other unlawful business practices.
Pre-market indication
HCA Healthcare stock trades at EUR 411.50 pre-market at Lang & Schwarz on October 14, 2026, at 8:24 a.m. CEST. The bid was EUR 409.50 and the ask was EUR 413.50. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of HCA Healthcare stock.
Additional dated market information
A Börse Hannover page for HCA Healthcare listed EUR 406.70 at 11:36 a.m. on October 13, 2026, with a bid of EUR 407.50 and an ask of EUR 417.50. The page identifies the instrument by ISIN US40412C1018 and names Börse Hannover as the venue.
Market context: Market report S&P 500.
